4//SEC Filing
Gemphire Therapeutics Inc. 4
Accession 0001596771-17-000041
$MTVACIK 0001638287operating
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:25 PM ET
Size
5.4 KB
Accession
0001596771-17-000041
Insider Transaction Report
Form 4
Gullans Steven R. Ph.D.
Director
Transactions
- Award
Employee Stock Option (right to buy)
2017-05-30+60,000→ 60,000 totalExercise: $10.26Exp: 2027-05-29→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests in 12 equal consecutive monthly increments, so that all of the shares will be vested on the one year anniversary of the date of grant, subject to acceleration upon the appointment of a permanent President and Chief Executive Officer.
Documents
Issuer
Gemphire Therapeutics Inc.
CIK 0001638287
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001638287
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 4:25 PM ET
- Size
- 5.4 KB